MYCOTA POWDER 70G

Mycota powder contains two active ingredients, zinc undecylenoate and undecylenoic acid. Mycota powder has antifungal and antibacterial properties. It is used for the treatment and prevention of athlete's foot. For the treatment and prevention of athlete?s foot Posology and method of administration Adults, Children and Elderly Treatment Each night and morning wash and thoroughly dry the affected parts and sprinkle on Mycota Powder (preferably after applying Mycota Cream or Spray to the area). Ensure a generous application between the toes and each day wear clean socks or stockings dusted inside with Mycota Powder. Continue treatment for one week after all evidence of infection has disappeared. Prevention Sprinkle Mycota Powder inside socks or stockings daily. Contraindications Hypersensitivity to any of the ingredients Special warnings and precautions for use The label states for external use only, keep all medicines out of the sight and reach of children. Contact with the eyes and mucous membranes should be avoided. Treatment should be discontinued if irritation is severe. Do not apply to broken skin. Excipient warnings: This medicine contains Emulsifying wax with 1.4% w/w Sodium laurilsulfate. Sodium laurilsulfate may cause local skin reactions (such as stinging or burning sensation) or increase skin reactions caused by other products when applied on the same area. This medicine contains Emulsifying wax with 1.36% w/w Cetostearyl alcohol. Cetosteryl alcohol may cause local skin reactions (e.g. contact dermatitis). This medicine contains fragrance with Euganol, which may cause an allergic reaction. Fertility, pregnancy and lactation Although there is no specific data available concerning the use of Mycota powder during pregnancy and lactation, it is not considered to constitute a hazard. Undesirable effects Hypersensitivity reactions may occasionally occur. Irritation of the skin may rarely occur. Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Pharmacy and poisons board portal via? https://pv.pharmacyboardkenya.org/padrs/add Overdose Excessive application to the skin is unlikely to cause untoward effects. In the unlikely event of ingestion of Mycota powder, symptoms of overdosage may include nausea, vomiting, diarrhoea and general gastrointestinal disturbances. Treatment need only be symptomatic.

KES 1,045.00

(Inclusive of all taxes)